Assembly Bill A8836

2023-2024 Legislative Session

Requires the commissioner of health to include in annual reports information regarding the cost and increase in cost of certain prescription drugs

download bill text pdf

Sponsored By

Current Bill Status - In Assembly Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

2023-A8836 (ACTIVE) - Details

See Senate Version of this Bill:
S8587
Current Committee:
Assembly Health
Law Section:
Public Health Law
Laws Affected:
Amd §277, Pub Health L
Versions Introduced in Other Legislative Sessions:
2019-2020: A7922
2021-2022: A741

2023-A8836 (ACTIVE) - Summary

Requires the commissioner of health to include in annual reports information regarding the cost and increase in cost of the ten prescription drugs on which the state expends the most money and which have had certain costs increased by fifty percent or more over the past five years or by ten percent or more during the previous calendar year.

2023-A8836 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   8836
 
                           I N  A S S E M B L Y
 
                             January 18, 2024
                                ___________
 
 Introduced by M. of A. BERGER -- read once and referred to the Committee
   on Health
 
 AN  ACT  to  amend  the  public health law, in relation to requiring the
   commissioner of  health  to  include  in  annual  reports  information
   regarding the cost and increase in cost of certain prescription drugs
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision 1 of section 277 of the public health  law,  as
 amended  by  section  18 of part A of chapter 56 of the laws of 2013, is
 amended to read as follows:
   1. The commissioner, in consultation with the drug utilization  review
 board,  shall  undertake  periodic  reviews,  at  least annually, of the
 preferred drug program which shall include consideration of:
   (a) the volume of prior authorizations being handled,  including  data
 on  the  number  and characteristics of prior authorization requests for
 particular prescription drugs;
   (b) the quality of the program's responsiveness, including the quality
 of the administrator's responsiveness;
   (c) complaints received from patients and providers;
   (d) (I) A LIST OF THE  TEN  PRESCRIPTION  DRUGS  ON  WHICH  THE  STATE
 EXPENDS  THE MOST MONEY AND FOR WHICH THE WHOLESALE ACQUISITION COST HAS
 INCREASED BY FIFTY PERCENT OR MORE OVER THE PAST FIVE YEARS  OR  BY  TEN
 PERCENT  OR  MORE  DURING  THE  PREVIOUS CALENDAR YEAR. THE COMMISSIONER
 SHALL: INCLUDE THE PERCENTAGE OF THE WHOLESALE ACQUISITION COST INCREASE
 FOR EACH DRUG ON THE LIST; RANK THE DRUGS ON THE LIST  FROM  THOSE  WITH
 THE  LARGEST  INCREASE  IN  WHOLESALE ACQUISITION COST TO THOSE WITH THE
 SMALLEST INCREASE; INDICATE WHETHER EACH DRUG WAS INCLUDED ON  THE  LIST
 BASED ON ITS COST INCREASE OVER THE PAST FIVE YEARS OR DURING THE PREVI-
 OUS  CALENDAR  YEAR,  OR BOTH; AND PROVIDE THE STATE'S TOTAL EXPENDITURE
 FOR EACH DRUG ON THE LIST DURING THE MOST RECENT CALENDAR YEAR; AND
   (II) A LIST OF THE TEN PRESCRIPTION DRUGS ON WHICH THE  STATE  EXPENDS
 THE  MOST  MONEY AND FOR WHICH THE COST TO THE STATE, NET OF REBATES AND
 OTHER PRICE CONCESSIONS, HAS INCREASED BY FIFTY PERCENT OR MORE OVER THE
 PAST FIVE YEARS OR BY TEN PERCENT OR MORE DURING THE  PREVIOUS  CALENDAR
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.